Skip to main content

Table 4 Characteristics of compounds less sensitive to ethnic influences and better candidates for global trials

From: Globalization of Alzheimer's disease clinical trials

Linear pharmacokinetics

Wide therapeutic dose range

Minimal metabolism or not metabolized by enzymes subject to genetic influences

High bioavailability

Little inter-subject variability in bioavailability

Low protein binding

Limited potential for drug-diet interactions

Limited potential for drug-drug interactions

Limited potential for abuse or inappropriate use

Not a prodrug

  1. Adapted from [1, 3, 23].